Named a Grand Stevie® Winner and Highest-Rated Nomination of the Year
Emota and AstraZeneca’s ASCO 2025 experience has been named a Grand Stevie® Winner and the highest-rated nomination of the year—recognising a new benchmark in sustainable congress design.
Discover how immersive storytelling and sustainable innovation transformed the congress experience.
Following the announcement of our Gold and Bronze wins at the American Business Awards®, we’re proud to share that the project has now received an even greater honour — being named a Grand Stevie® Winner.
Awarded to the highest-scoring entries across all categories, the Grand Stevie Awards represent the “best of show” within the American Business Awards programme. Emota’s submission, “From Vision to Legacy: AstraZeneca and Emota Driving Sustainable Innovation,” achieved an outstanding average judges’ score of 9.88 out of 10, making it the Highest-Rated Nomination of the Year.
The recognition celebrates our partnership with AstraZeneca to create a more immersive, measurable, and sustainable presence at ASCO 2025 — the world’s largest oncology congress.
Judges praised the project for transforming sustainability from a behind-the-scenes operational consideration into a visible and engaging part of the congress experience, while also delivering measurable environmental and commercial impact.
This latest recognition reinforces the project’s role as more than a one-off exhibition stand. It represents a scalable new model for pharmaceutical congress experiences — one that combines immersive storytelling, intelligent design, and sustainable innovation at global scale.
